DCC’s long-running misunderstanding with the stock market appeared to continue on Tuesday, when the group delivered the promised disposal of its healthcare division and was rewarded with a share price drop of over 4.5 per cent in the day’s trading. The Dublin-headquartered, London-listed, FTSE 100 company has long baffled equity investors, despite generating profits and dividends like clockwork for decades. A three-legged conglomerate operating across energy, healthcare supplies, and technology, it has never fit neatly in any box.  Was DCC purely a listed investment vehicle like Berkshire Hathaway? A Japanese-style keiretsu with fingers in multiple industrial pies? A future champion…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .